FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116768113> ?p ?o ?g. }

• W2116768113 endingPage "2870" @default.
• W2116768113 startingPage "2865" @default.
• W2116768113 abstract "The majority of patients with systemic mast cell disease express the imatinib-resistant Asp816Val (D816V) mutation in the KIT receptor tyrosine kinase. Limited treatment options exist for aggressive systemic mastocytosis (ASM) and mast cell leukemia (MCL). We evaluated whether PKC412, a small-molecule inhibitor of KIT with a different chemical structure from imatinib, may have therapeutic use in advanced SM with the D816V KIT mutation. We treated a patient with MCL (with an associated myelodysplastic syndrome (MDS)/myeloproliferative disorder [MPD]) based on in vitro studies demonstrating that PKC412 could inhibit D816V KIT-transformed Ba/F3 cell growth with a 50% inhibitory concentration (IC50) of 30 nM to 40 nM. The patient exhibited a partial response with significant resolution of liver function abnormalities. In addition, PKC412 treatment resulted in a significant decline in the percentage of peripheral blood mast cells and serum histamine level and was associated with a decrease in KIT phosphorylation and D816V KIT mutation frequency. The patient died after 3 months of therapy due to progression of her MDS/MPD to acute myeloid leukemia (AML). This case indicates that KIT tyrosine kinase inhibition is a feasible approach in SM, but single-agent clinical efficacy may be limited by clonal evolution in the advanced leukemic phase of this disease. (Blood. 2005; 106:2865-2870)" @default.
• W2116768113 created "2016-06-24" @default.
• W2116768113 creator A5004151297 @default.
• W2116768113 creator A5005810412 @default.
• W2116768113 creator A5011691837 @default.
• W2116768113 creator A5015491065 @default.
• W2116768113 creator A5015788207 @default.
• W2116768113 creator A5018089497 @default.
• W2116768113 creator A5022832205 @default.
• W2116768113 creator A5027429869 @default.
• W2116768113 creator A5030271449 @default.
• W2116768113 creator A5045163489 @default.
• W2116768113 creator A5048380473 @default.
• W2116768113 creator A5051933344 @default.
• W2116768113 creator A5054231625 @default.
• W2116768113 creator A5061203160 @default.
• W2116768113 creator A5065621786 @default.
• W2116768113 creator A5070723591 @default.
• W2116768113 creator A5076258077 @default.
• W2116768113 creator A5080510903 @default.
• W2116768113 creator A5091057405 @default.
• W2116768113 date "2005-10-15" @default.
• W2116768113 modified "2023-10-02" @default.
• W2116768113 title "Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation" @default.
• W2116768113 cites W1255933066 @default.
• W2116768113 cites W1513438412 @default.
• W2116768113 cites W1601094160 @default.
• W2116768113 cites W1682346499 @default.
• W2116768113 cites W1983999811 @default.
• W2116768113 cites W1993327121 @default.
• W2116768113 cites W2000893535 @default.
• W2116768113 cites W2001785591 @default.
• W2116768113 cites W2007266721 @default.
• W2116768113 cites W2012245921 @default.
• W2116768113 cites W2014987515 @default.
• W2116768113 cites W2024510824 @default.
• W2116768113 cites W2034004457 @default.
• W2116768113 cites W2042328377 @default.
• W2116768113 cites W2046632940 @default.
• W2116768113 cites W2048993739 @default.
• W2116768113 cites W2055764602 @default.
• W2116768113 cites W2064435481 @default.
• W2116768113 cites W2075428599 @default.
• W2116768113 cites W2077810015 @default.
• W2116768113 cites W2095226581 @default.
• W2116768113 cites W2097623437 @default.
• W2116768113 cites W2103827225 @default.
• W2116768113 cites W2117754708 @default.
• W2116768113 cites W2153345005 @default.
• W2116768113 cites W2165720262 @default.
• W2116768113 cites W2469685867 @default.
• W2116768113 doi "https://doi.org/10.1182/blood-2005-04-1568" @default.
• W2116768113 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1895309" @default.
• W2116768113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15972446" @default.
• W2116768113 hasPublicationYear "2005" @default.
• W2116768113 type Work @default.
• W2116768113 sameAs 2116768113 @default.
• W2116768113 citedByCount "229" @default.
• W2116768113 countsByYear W21167681132012 @default.
• W2116768113 countsByYear W21167681132013 @default.
• W2116768113 countsByYear W21167681132014 @default.
• W2116768113 countsByYear W21167681132015 @default.
• W2116768113 countsByYear W21167681132016 @default.
• W2116768113 countsByYear W21167681132017 @default.
• W2116768113 countsByYear W21167681132018 @default.
• W2116768113 countsByYear W21167681132019 @default.
• W2116768113 countsByYear W21167681132020 @default.
• W2116768113 countsByYear W21167681132021 @default.
• W2116768113 countsByYear W21167681132022 @default.
• W2116768113 countsByYear W21167681132023 @default.
• W2116768113 crossrefType "journal-article" @default.
• W2116768113 hasAuthorship W2116768113A5004151297 @default.
• W2116768113 hasAuthorship W2116768113A5005810412 @default.
• W2116768113 hasAuthorship W2116768113A5011691837 @default.
• W2116768113 hasAuthorship W2116768113A5015491065 @default.
• W2116768113 hasAuthorship W2116768113A5015788207 @default.
• W2116768113 hasAuthorship W2116768113A5018089497 @default.
• W2116768113 hasAuthorship W2116768113A5022832205 @default.
• W2116768113 hasAuthorship W2116768113A5027429869 @default.
• W2116768113 hasAuthorship W2116768113A5030271449 @default.
• W2116768113 hasAuthorship W2116768113A5045163489 @default.
• W2116768113 hasAuthorship W2116768113A5048380473 @default.
• W2116768113 hasAuthorship W2116768113A5051933344 @default.
• W2116768113 hasAuthorship W2116768113A5054231625 @default.
• W2116768113 hasAuthorship W2116768113A5061203160 @default.
• W2116768113 hasAuthorship W2116768113A5065621786 @default.
• W2116768113 hasAuthorship W2116768113A5070723591 @default.
• W2116768113 hasAuthorship W2116768113A5076258077 @default.
• W2116768113 hasAuthorship W2116768113A5080510903 @default.
• W2116768113 hasAuthorship W2116768113A5091057405 @default.
• W2116768113 hasBestOaLocation W21167681131 @default.
• W2116768113 hasConcept C104317684 @default.
• W2116768113 hasConcept C109159458 @default.
• W2116768113 hasConcept C121608353 @default.
• W2116768113 hasConcept C126322002 @default.
• W2116768113 hasConcept C170493617 @default.
• W2116768113 hasConcept C2022786 @default.
• W2116768113 hasConcept C203014093 @default.

• next